Moreover, Inoue et al. reported that ADSCs derived from T2DM patients show a reduced secretion of VEGF, which are associated with an impaired in vivo angiogenic capacity in xenograft experiments using a mouse model of hindlimb ischemia [7]. The gene discussed is VEGFA; the disease is type 2 diabetes mellitus.